Range Impact, Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending September 30, 2024. The company experienced a substantial decline in revenue, with total revenues for the three months amounting to $2.2 million, down from $5.5 million in the same period of 2023. For the nine months ended September 30, 2024, revenues were $8.4 million, compared to $12.5 million in the prior year. This decline was primarily attributed to decreased contributions from the Range Reclaim and Range Minerals segments, including a notable $3.3 million drop in quarterly revenue linked to a one-time project in the previous year.

The company's gross profit turned into a loss, reporting $(392,928) for Q3 2024, compared to a gross profit of $2.9 million in Q3 2023. For the nine-month period, the gross loss was $(523,003), contrasting sharply with a gross profit of $4.4 million in the prior year. The operating loss for Q3 2024 was $(866,870), a stark decline from an operating income of $1.8 million in Q3 2023. The net loss for the quarter was $(4.9 million), compared to a net income of $3.4 million in the same quarter of the previous year.

Total assets decreased significantly to $10.4 million as of September 30, 2024, down from $23.8 million at the end of 2023. Current assets also fell to $5.1 million, with cash and cash equivalents dropping to $244,586 from $2.2 million at the end of 2023. The company’s total liabilities were reported at $7.2 million, down from $14.2 million, while stockholders' equity decreased to $3.3 million from $9.6 million.

Strategically, Range Impact made notable changes, including the acquisition of Collins Building & Contracting, Inc. in August 2023, which was later sold in August 2024 due to operational challenges, resulting in a loss of $3.0 million. Additionally, the company sold its drug development subsidiary, Graphium Biosciences, in September 2024, recognizing minimal cash proceeds from the transaction.

The company’s ability to continue as a going concern is in doubt, as it faces ongoing financial losses and cash flow issues. As of September 30, 2024, Range Impact reported a working capital of $335,307, a decrease from $753,756 at the end of 2023, and indicated that it may not have sufficient funds to operate for the next 12 months.

About RANGE IMPACT, INC.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.